Navigation Links
AstraZeneca Survey: Healthcare Professionals Leading Source of Information on Company's Prescription Savings Programs
Date:7/23/2008

WILMINGTON, Del., July 23 /PRNewswire-FirstCall/ -- More than a third of the people who contacted AstraZeneca (NYSE: AZN) to inquire about the company's prescription savings programs learned of the programs from their doctors or pharmacists, according to a year-long survey of more than 12,000 patients.

The survey found that 35 percent of the patients who called AstraZeneca's information center regarding prescription savings programs said they were referred by healthcare professionals. Another 14 percent learned of the program from brochures, which also are available in doctors' offices, hospitals, clinics and pharmacies.

"AstraZeneca understands that our medicines don't do patients any good if they cannot afford to pay for them," said Tony Zook, President and CEO, AstraZeneca North America. "We connect families with our patient assistance programs in a variety of ways, but our most valuable tool is providing doctors and pharmacists with the information they need to help their patients."

As they meet with healthcare providers, AstraZeneca's pharmaceutical sales specialists share up-to-date clinical information on medicines and other issues impacting patient care, including adherence, educational materials and prescription savings programs.

The study's data shows that the message on patient assistance programs is getting through in a variety of ways. AstraZeneca asked 12,487 patients who contacted its information center between April 2007 and March 2008 where they learned about the company's patient assistance programs. The results:

-- Doctor/pharmacist 35 percent

-- Brochure 14 percent

-- Advertising 9 percent

-- AZ Web sites 7 percent

<
'/>"/>
SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Weitz & Luxenberg Files Seroquel Diabetes Lawsuit Against AstraZeneca
2. Cellectricon and AstraZeneca - Partners in New High Throughput Ion Channel Drug Discovery Technology
3. WuXi PharmaTech (NYSE: WX) Expands Collaboration With AstraZeneca
4. AstraZeneca Supports Transparency Legislation on Payments to Health Care Providers
5. Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation
6. AstraZenecas Zactima to Earn Almost Five Percent Patient Share in the Treatment of Non-Small-Cell Lung Cancer by 2016
7. Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery
8. AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC)
9. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
10. AstraZeneca Response to February 21, 2008 Ruling In Re: Alabama Medicaid Pharmaceutical AWP Litigation - cv2005-219 - Circuit Court of Montgomery, Alabama
11. Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Nov. 24 /PRNewswire-Asia/ -- NOD Pharmaceuticals ...e (PTO) has allowed the patent application for,its..., NOD technology is a highly efficient appr...adhesive nano-particles to enable oral delivery of...echnology is a platform technology,that can be app...
(Date:11/24/2009)...e FBI recently approved the Promega PowerPlex 16 H...or generating DNA records for the National DNA Ind...USA (PRWEB) -- The FBI recently approved the Prome...tories participating in, or generating DNA records...urrently contains more than seven million profiles...
(Date:11/24/2009)...ov. 24, 2009 Arena Pharm...y that the company is scheduled to present at the ...n December 1, 2009 at 11:30 a.m. Eastern Time (8:3...in New York City. Jack Lief, Arena,s President and...an overview of the company, including its clinical...
(Date:11/24/2009)...emical Abstracts Service (CAS), the global expert ...nt office is now the world,s leading producer of p...railed Japan,s patent office, the World Intellectu...ates Patent and Trademark Office (USPTO) for more ...in 2006, and exceeded Japan for the first time on ...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
...,(Nasdaq: GENZ ) has announced findings from an i...and patient satisfaction following,viscosupplement...nts with,osteoarthritis of the knee. This landmark...nee pain relief and a higher rate of patient satis... Raghu Raman and a team of doctors,from the Depart...
...uticals, Inc. (Nasdaq: MBRK ), a pharmaceutical c...ovel anti-infective products, today,announced that...lenTactics,LLC to lead its field force hiring effo...moxicillin extended-release tablets, 775mg) launch...9., MiddleBrook President and CEO John Thievon co...
...008 Third Quarter and 5% for the 2008 Fir...th in Pharmaceuticals Division Led by Sol...evnar +13% , - Guidance for 2008 Full Year D...ems, Revised to a Range of $3.49 to $3.55 , ...SON, N.J., Oct. 22 Wyeth (NYSE: WYE ),today repo...
Other Biology Technology:Independent Study Reveals SYNVISC(R) Offers Longer Knee Pain Relief and Greater Patient Satisfaction for Those Suffering from Osteoarthritis of the Knee 2Independent Study Reveals SYNVISC(R) Offers Longer Knee Pain Relief and Greater Patient Satisfaction for Those Suffering from Osteoarthritis of the Knee 3MiddleBrook Hires TalenTactics to Recruit National Field Force 2MiddleBrook Hires TalenTactics to Recruit National Field Force 3Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 2Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 3Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 4Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 5Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 6Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 7Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 8Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 9Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 10Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 11Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 12Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 13Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months 14
(Date:11/26/2009)...ed deer have been caught in the hunters, sights fo...than decorative. They are lethal weapons that stag...The University of York, UK, has been intrigued by ...century and has become fascinated by the mechanica...laboration with Tomas Landete-Castillejos at the U...
(Date:11/26/2009)... are the bare essentials of life, the indispensabl...survive on its own? Can we describe the molecular ...ganism functions as a system? These are just some ...between the European Molecular Biology Laboratory ...egulacio Genmica (CRG) in Barcelona, Spain, set ou...
(Date:11/25/2009)...lives. In addition to mammalian immune systems tha...ed bacteriophages, viruses that kill half the bact... and another class of microorganisms called archae...s deep-sea volcanic vents) manage just fine, thank... system that helps protect them from many viruses ...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Nationwide Relocation Services Support Breast Cancer Awareness 61210 1Nationwide Relocation Services Support Breast Cancer Awareness 61210 2Nationwide Relocation Services Support Breast Cancer Awareness 61210 3SourceMedical Earns Cardinal Health Innovation Award 61207 1SourceMedical Earns Cardinal Health Innovation Award 61207 2Fresh Throne Eco Friendly Bathroom Spray Celebrates Launch by Donating to Salvation Army 61204 1Fresh Throne Eco Friendly Bathroom Spray Celebrates Launch by Donating to Salvation Army 61204 2
...ratory researchers explore new frontier of metabol...ntists genetic roadmaps to link certain genes to d... by certain genes spawned the field of proteomics....ent of Energy,s Ames Laboratory at Iowa State Univ...ing to begin understanding the chemical processes ...
...of above-ground nuclear testing provide a way to d...arbon-14 produced by above-ground nuclear testing ...tists with a more precise way to determine a perso...lp in the identification of victims of Hurricane K...technique, developed by researchers at Lawrence Li...
...ia is a hereditary blood disease, primarily affect...otentially life-threatening ,bleeds,. About one in... severe, moderate or mild form. People with haemop...Factor VIII clotting protein. , Professor Denisa W...breaking discoveries that provide hope of an alter...
Other Biology News:Making plant cells work like miniature factories 2Making plant cells work like miniature factories 3New tooth enamel dating technique could help identify disaster victims 2New tooth enamel dating technique could help identify disaster victims 3Promising therapies for haemophilia & heart disease 2
Rabbit Anti-JNK1, phospho (Thr183 / Tyr185) Polyclonal Antibody, Unconjugated from Abcam
Cytofix Buffer from BD Biosciences Pharmingen
Perm/Wash Buffer from BD Biosciences Pharmingen
BD Phosflow Fix Buffer I from BD Biosciences Pharmingen
Biology Products: